Biotech, pharmaceutical and life sciences firms all hope AI will streamline drug development and make it more efficient, and 38% have already adopted the technology, in response to Deloitte. QuantHealth goals to participate with...
Artificial intelligence (AI) drug development company Causaly has attracted an investment of 60 million dollars (about 76 billion won). Funds are pouring into the AI ​​bio field following the recursion, which received an...
The primary drug created only by artificial intelligence (AI) without human intervention enters clinical trials.
CNBC reported on the twenty ninth (local time) that Insilico Medicine, a biotechnology startup in Hong Kong, has developed...
ML Models Must Match Their Use Cases in Drug DiscoveryCo-authored by LabGenius’ CTO, Leo Wossnig.Drug discovery is historically slow, expensive, and riddled with failures — AI/ML is changing this paradigm.The drug development process stays...
French startup Iktos has secured €15.5 million in Series A funding for its AI-powered drug discovery platform.The round was co-led by M Ventures and Debiopharm Innovation Fund, with participation from Omnes Capital, and can...